Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CAGEKID: Cancer Genomics of the Kidney - Targeted Sequencing

ABSTRACT: The aim of CAGEKID is to carry out comprehensive detection of DNA markers for conventional (clear cell) renal carcinoma. The project includes complete analysis of somatic and constitutional DNA variation, methylation patterns and expression in a large number of constitutional/tumor pairs. CAGEKID is a part of the International Cancer Genome Consortium, ICGC.

PROVIDER: EGAS00001007004 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

CAGEKID: Cancer Genomics of the Kidney

Project description:The aim of CAGEKID is to carry out comprehensive detection of DNA markers for conventional (clear cell) renal carcinoma. The project includes complete analysis of somatic and constitutional DNA variation, methylation patterns and expression in a large number of constitutional/tumor pairs. CAGEKID is a part of the International Cancer Genome Consortium, ICGC.

| EGAS00001000083 | EGA

Cagekid_Release27 - samples

| EGAD00001004018 | EGA

Transcriptome analysis of renal cancer from the Cancer Genomics of the Kidney (CAGEKID) project

Project description:The incidence of renal cell carcinoma (RCC) is increasing worldwide, and its prevalence is particularly high in some parts of Central Europe. The study describes transcriptome sequencing of clear cell RCC (ccRCC), the most common form of the disease, in patients from four different European countries with contrasting disease incidence.

2014-10-29 | E-MTAB-3033 | biostudies-arrayexpress

CageKid Tumor Dataset - samples

Project description:Dataset of CageKid Tumor DNA samples

| EGAD00001000717 | EGA

Therapeutic Delivery of Targeted Nanoparticle Cannabinoid Equivalents

Project description:Nanoparticles and nano delivery systems are continuously being refined and developed as means of treating numerous human diseases by site-specific, and target-oriented delivery of medicines. The nanoparticles can carry therapeutic cargo or be medicinal themselves by virtue of their constitutional structural components. Here we report the ability of synthetic N-acylethanolamides, linoleoylethanolamide (LEA) and oleoylethanolamide (OEA), with endocannabinoid-like activity, to form spherical colloidal nanoparticles that when conjugated with tissue specific homing molecules, can localise to specific areas of the body, and reduce inflammation. The opportunities to mediate pharmacological effects of endocannabinoids at targeted sites provides a novel drug delivery system with increased medicinal potential to treat many diseases in many areas of medicine.

2022-10-19 | GSE206164 | GEO

CageKid Tumor RNAseq Dataset - samples

Project description:Dataset of CageKid Tumor RNA samples

| EGAD00001000718 | EGA

CageKid Normals RNAseq Dataset - samples

Project description:Dataset of CageKid Normal RNA samples

| EGAD00001000719 | EGA

CageKid tumor-normal paired RNAseq Dataset - samples

Project description:Dataset of CageKid tumor-normal paired RNA samples

| EGAD00001000720 | EGA

Individuals with excess numbers of germline de novo CNVs [NimbleGen]

Project description:We describe a multiple de novo CNV (MdnCNV) phenomenon in which individuals with genomic disorders carry five to ten constitutional de novo CNVs. Five such families are studied, which consists of four trios and one singleton. Various array platforms are used to interogate these families to identify de novo CNVs.

2016-10-14 | GSE87909 | GEO

Individuals with excess numbers of germline de novo CNVs [Illumina]

2016-10-14 | GSE87838 | GEO